<DOC>
	<DOCNO>NCT01217008</DOCNO>
	<brief_summary>The purpose study evaluate safety GRNOPC1 administer single time-point 7 14 day post injury , inclusive , patient neurologically complete spinal cord injury ( SCI ) .</brief_summary>
	<brief_title>Safety Study GRNOPC1 Spinal Cord Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Major Neurologically complete , traumatic SCI ( ASIA Impairment Scale A ) , zone partial preservation &lt; 5 level Last fully preserve neurological level T3 T11 From 18 65 year age time injury Single spinal cord lesion Informed consent protocol companion long term followup protocol must provide document ( i.e. , sign informed consent form ) later 11 day follow injury Able participate elective surgical procedure inject GRNOPC1 714 day follow SCI Major SCI due penetrate trauma Traumatic anatomical transection laceration spinal cord Any concomitant injury preexist condition interferes performance , interpretation validity neurological examination Inability communicate effectively neurological examiner Significant organ damage systemic disease would create unacceptable risk surgery immunosuppression History malignancy Pregnant nursing woman Body mass index ( BMI ) &gt; 35 weight &gt; 300 lb . Active participation another experimental procedure/intervention</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Spinal Cord Injury</keyword>
	<keyword>GRNOPC1</keyword>
</DOC>